The NK cell therapy market is anticipated to grow from USD 635 million in 2025 to USD 2,891.55 million by 2034, with a compound annual growth rate (CAGR) of 18.25% during the forecast period from 2025 to 2034.

NK Cell Therapy Market Scope

NK Cell Therapy Market Share, By Type

Reason for segmentation:

• NK Cell Therapy holds a higher percentage due to its established dominance in the market, expected to grow significantly over the next decade.
• CAR-NK Cell Therapy is a newer segment with strong growth prospects but starts with a lower share as it is still in the expansion phase.

NK Cell Therapy Market Share, By Application

Reason for segmentation:

• Cancer represents the largest share, as NK cell therapies have shown great potential in treating various cancers, particularly with rising cancer incidences globally.
• Infectious Diseases also hold a notable share due to growing efforts in addressing infectious diseases through novel immunotherapies.
• Beauty & Anti-Aging has a smaller share, indicating the niche application of NK cell therapies in aesthetic treatments compared to medical ones.

NK Cell Therapy Market Share, By Region

Reason for segmentation:

• North America leads due to the strong healthcare infrastructure and adoption of advanced therapies, especially in the U.S., where there is significant investment in immunotherapies.
• Europe and Asia-Pacific follow, with Europe showing consistent demand for novel therapies and Asia-Pacific benefiting from growing research and healthcare infrastructure in countries like China and Japan.
• Latin America and Middle East & Africa hold smaller shares, reflecting lower market maturity and infrastructure limitations for NK cell therapies.

NK Cell Therapy Market Companies

• Fate Therapeutics
• NKarta Therapeutics
• Artiva Biotherapeutics
• Indapta Therapeutics
• ImmunityBio
• ONK Therapeutics
• CytoLynx Therapeutics
• Glycostem Therapeutics
• Kangstem Biotech
• Immuneel Therapeutics
• GAIA BioMedicine

NK Cell Therapy Market Segments

By Type

• NK Cell Therapy
• CAR-NK Cell Therapy

By Application

• Cancer
• Infectious Diseases
• Gastrointestinal Diseases
• Beauty and Anti-Aging
• Others

By Region

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

List of Tables:

• Table 1: NK Cell Therapy Market by Type (Shares by Type)
  • Description: This table breaks down the NK Cell Therapy market based on the type of NK cell therapies. It provides the market size in USD Bn for the years 2024 to 2034, along with their share percentages.
  • Sub-segments:
    • NK Cell Therapy
    • CAR-NK Cell Therapy
    • Total Market (Combined)
• Table 2: NK Cell Therapy Market by Application (Shares by Application)
  • Description: This table presents the market share for NK cell therapies across different medical applications. The breakdown is provided for each year from 2024 to 2034, along with the share percentage of each application.
  • Sub-segments:
    • Cancer
    • Infectious Diseases
    • Gastrointestinal Diseases
    • Beauty & Anti-Aging
    • Others
• Table 3: NK Cell Therapy Market by Region (Shares by Region)
  • Description: This table categorizes the NK cell therapy market by region, showing the market size in USD Bn and the percentage share for each region from 2024 to 2034.
  • Sub-segments:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa

List of Figures:

• Figure 1: Market Share by Type for NK Cell Therapy
  • Description: This figure visualizes the market share by type of NK cell therapy for the year 2024. It provides a clear, graphical representation of the proportion between NK Cell Therapy and CAR-NK Cell Therapy, highlighting their contributions to the total market.
  • Sub-segments:
    • NK Cell Therapy
    • CAR-NK Cell Therapy
• Figure 2: Market Share by Application for NK Cell Therapy
  • Description: This figure presents the market share by application of NK cell therapies for the year 2024. It offers a visual breakdown of how different therapeutic applications contribute to the overall market.
  • Sub-segments:
    • Cancer
    • Infectious Diseases
    • Gastrointestinal Diseases
    • Beauty & Anti-Aging
    • Others
• Figure 3: Market Share by Region for NK Cell Therapy
  • Description: This figure shows the market share by region for NK cell therapies in 2024. It provides a visual comparison of regional market distribution, emphasizing the dominance of North America.
  • Sub-segments:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa
• Figure 4: Projected Growth of NK Cell Therapy Market by Type (2024–2034)
  • Description: This figure outlines the projected growth of the NK Cell Therapy and CAR-NK Cell Therapy segments over the next decade, based on CAGR.
  • Sub-segments:
    • NK Cell Therapy
    • CAR-NK Cell Therapy
• Figure 5: Projected Growth of NK Cell Therapy Market by Application (2024–2034)
  • Description: This figure shows the projected growth of NK cell therapies in various medical applications over the next decade, highlighting the future dominance of cancer treatments.
  • Sub-segments:
    • Cancer
    • Infectious Diseases
    • Gastrointestinal Diseases
    • Beauty & Anti-Aging
    • Others
• Figure 6: Projected Growth of NK Cell Therapy Market by Region (2024–2034)
  • Description: This figure displays the projected growth in the NK Cell Therapy market across different regions, forecasting the market’s expansion in North America, Europe, and Asia-Pacific.
  • Sub-segments:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa
• Figure 7: Comparative Market Share of NK Cell Therapy Applications in 2034
  • Description: A graphical representation showing the market share distribution of NK cell therapy applications in 2034. This figure illustrates how cancer will maintain its dominant position in the market by 2034.
  • Sub-segments:
    • Cancer
    • Infectious Diseases
    • Gastrointestinal Diseases
    • Beauty & Anti-Aging
    • Others